Article
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.
Journal of the National Cancer Institute - 2 Mar 2005
Shigematsu Hisayuki, Lin Li, Takahashi Takao, Nomura Masaharu, Suzuki Makoto, Wistuba Ignacio I, Fong Kwun M, Lee Huei, Toyooka Shinichi, Shimizu Nobuyoshi, Fujisawa Takehiko, Feng Ziding, Roth Jack A, Herz Joachim, Minna John D, Gazdar Adi F
Abstract excerpt
BACKGROUND: Mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene in lung cancers are associated with increased sensitivity of these cancers to drugs that inhibit EGFR kinase activity. However, the role of such mutations in the pathogenesis of lung cancers is unclear. METHODS: We sequenced exons 18-21 of the EGFR TK domain from genomic DNA isolated from 617...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
